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. . . statistical
methods are playing
an increasingly
important role in
medical (especially
clinical) research,
are becoming more
complex, and are
making it challeng-
ing for even expe-
rienced investiga-
tors to interpret the
literature . . .“Facts are stubborn things, but statistics are more pliable.”
—Mark Twain (1)
t has often been said in the halls of academia that physicians would have difficulty
critically reading the medical literature if they had never done research themselves.
I believe this refers to the need to be able to evaluate the validity of the methods
nd analysis of a publication. Specifically, readers must be able to determine that a paper
as included the appropriate study group, employed valid and accurate technology,
liminated confounding variables, insured adequate power, selected proper end points,
nd distinguished association from cause. However, I am impressed that statistical
ethods are playing an increasingly important role in medical (especially clinical)
esearch, are becoming more complex, and are making it challenging for even
xperienced investigators to interpret the literature accurately.
I must confess to always having viewed studying statistics as similar to a screening
olonoscopy; I knew that it was important and good for me, but there was little that was
leasant or fun about it. It seems that this impression was shared by many others. Deri-
ive comments about statistics were common, as evidenced by the opening quotation
rom Mark Twain and the famous statement of Benjamin Disraeli (1) that there are 3
inds of lies: lies, damned lies, and statistics. One of my mentors quipped that if he said
o a desk “arise” 100 times, and it floated in the air only once, this would be very signif-
cant, but not statistically significant. Despite their critical role in science, statistics
ometimes seemed to be used to prove a hypothesis rather than to test one, and this im-
ression has persisted as the techniques have become more complicated.
When I first began to do research, the commonly employed statistical methods were
elatively simple. Most data could be analyzed by the Student t test, chi-square, linear
egression, or multivariable analysis. As time has gone on, however, both the number
nd complexity of statistical approaches have become greater. A description of statistical
nalysis now typically occupies a substantial part of the Methods section of each manu-
cript. We currently have 2 Associate Editors at JACC who are statisticians and who
eview every manuscript before publication. Interestingly, it has been our experience that
greement among statistical experts is often no greater than it is in other areas of cardio-
ascular medicine. It is not difficult to imagine the dilemma created when 2 statisticians
isagree and debate in terminology understandable largely only by those in the field.
Of the statistical approaches that have been applied more recently, 2 stand out as be-
ng particularly frequent and contentious. Propensity scores are utilized in many reports
n an attempt to adjust for variables inherent in the lack of randomization. Noninferior-
ty testing is often employed to document that a new diagnostic modality is equivalent
o an existing technique, or that a new therapy is equal to one that has been shown toBrainy Quote. Benjamin Disraeli Quotes. Available at: http://www.brainyquote.com/quotes/quotes/b/q107958.html. Accessed
eptember 29, 2008.
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October 21, 2008:1430–1 Editor’s Pagee more effective than placebo. Both have significant limi-
ations and often engender spirited discussions at our Ed-
torial Board meetings.
The results of a clinical trial may be due either to the
ntervention tested or to pre-existing confounding vari-
bles that differ between treated and control groups. Pro-
pective trials that randomize study patients are the best
ay to eliminate such variables. In observational studies,
owever, variables that can affect prognosis usually exist
nd may influence the selection of management. Propen-
ity analysis is a statistical method to correct for such
onfounders post-hoc by identifying factors with the po-
ential to affect outcome and creating a score for these
ariables for each individual subject. The subjects can
hen be matched for their score so that these variables can
e eliminated or minimized.
Observational studies are less expensive and usually re-
uire less time than randomized clinical trials. In addi-
ion, they generally provide a wider spectrum of patients.
herefore, the potential of a propensity score to overcome
he lack of randomization is very seductive. However, dif-
erent approaches to propensity analysis exist, and errors
n the model such as the failure to use interaction terms
ay result in bias. Moreover, propensity analysis typically
esults in a comparison of groups with a similar composite
f variables, but not necessarily the same type or severity.
he most important limitation of a propensity score,
owever, is that it addresses only overt identifiable factors
nd cannot account for hidden confounders. Regardless of
ow many factors are identified (I am aware of one analy-
is that evaluated 74), uncertainty will always exist as to
hether you have captured the (often intangible) reasons
hat 1 patient was managed differently from another. For
his reason, many of our reviewers, and some of our edi-
ors, feel that the propensity score is fatally flawed and
ive it little credence. At the very least, sensitivity analysis
hould be attempted to indicate the level of hidden bias
hat would be required to alter the conclusions of the
tudy (2).
When a therapy exists that has proven to be superior to
lacebo, or a diagnostic technique is available that is ac-
eptably accurate is available, an alternate modality of
qual or nearly equal efficacy may be more desirable if it
as beneficial ancillary characteristics. Thus, a therapy
ith fewer side effects or a less expensive diagnostic test
ould not need to be superior to existing modalities. In
uch cases, noninferiority testing is often carried out (3).
oninferiority testing requires that the efficacy of the ex-sting modality be accurately quantified, which may be
3omplicated when multiple prior studies are available.
ince the new study may involve patients with different
haracteristics than in prior reports, a noninferiority mar-
in is defined that establishes the greatest decrease in effi-
acy one will accept in return for the benefits of the new
odality. This noninferiority margin is usually based on
linical judgment and is therefore somewhat subjective; it
s usually 10% to 20%.
In addition to the variability inherent in determining
he margin, nuances in the statistical aspects of noninferi-
rity trials have been the source of criticism. In fact, 1
aper reviewed 8 recently published cardiovascular clinical
oninferiority trials and was able to confirm noninferiority
n only 4 (3). When these statistic issues are combined
ith the frequent use of composite end points and the
iffering classification of side effects as adverse events or
rimary end points, it is not surprising that noninferiority
rials are often viewed with caution.
The ability to critically read the medical literature is
ecoming increasingly difficult, even for investigators.
he statistical aspects of the design and analysis of
linical trials have become more complex and of greater
mportance to the conclusions that are drawn from the
ata. At times it is difficult to determine if statistics are
eing used to analyze the data or substantiate it. Some
tatistical approaches, such as propensity scores and
oninferiority testing, are clearly imperfect or seriously
awed. Nevertheless, they may contribute to treatment
ecommendations and/or reimbursement decisions. It ap-
ears that these statistical matters have resulted in some
rustration and skepticism on the part of our readers. As
n editor, and as a reader myself, I am sympathetic to
hese sentiments.
ddress correspondence to:
r. Anthony N. DeMaria
ditor-in-Chief, Journal of the American College of Cardiology
655 Nobel Drive, Suite 630
an Diego, California 92112
-mail: ademaria@acc.org
EFERENCES
. The Quotations Page. Available at: http://www.quotationspage.com/
quote/27556.html. Accessed September 29, 2008.
. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments:
analytic strategies using propensity scores. Ann Intern Med 2002;137:
693–6.. Kaul S, Diamond GA. Good enough: a primer on the analysis and
interpretation of noninferiority trials. Ann Intern Med 2006;145:62–9.
